Meningococcal vaccine failure in conjunction with an unusual meningococcal cluster in southern Tasmania
DOI:
https://doi.org/10.33321/cdi.2005.29.15Keywords:
invasive meningococcal disease, Neisseria meningiditis, vaccine failure, nucleic acid amplification testAbstract
A report of an unusual family cluster of group C invasive meningococcal disease in Tasmania. This unusual case cluster raises several important issues of public health significance regarding vaccine failure and nucleic acid amplification testing use in the setting of invasive meningococcal disease. Commun Dis Intell 2005;29:159–163.
Downloads
References
Annual Report of the Australian Meningococcal Surveillance Programme, 2000. Commun Dis Intell 2001;25:113–121.
Balmer P, Borrow R, Miller E. Impact of meningococcal C conjugate vaccine in the UK. J Med Microbiol 2002;51:717–722 [Review].
Public Health Laboratory Service and the Institute of Child Health. Surveillance of impact of meningococcal serogroup C conjugate vaccination programme in England and Wales and protocol for investigation of vaccine failures. January 2001.
De Pauw B, Donnelly J. Infections in special hosts. In: Mandell G, Bennett J and Dolin R, eds. Principles and Practice of Infectious Diseases. Churchill Livingstone, 2000.
Russell J, Jolley K, Feavers I, Maiden MC, Suker J. PorA variable regions of Neisseria meningitidis. Emerg Infect Dis 2004;April.
Goldblatt D, Borrow R, Mi ller E. Natural and vaccine-induced immunity and immunologic memory to Neisseria meningitidis serogroup C in young adults. J Infect Dis 2002;185:397–400.
Wang J, Jarvis GA, Achtman M, Rosenqvist E, Michaelsen TE, Aase A, et al. Functional activities and immunoglobulin variable regions of human and murine monoclonal antibodies specific for the P1.7 PorA protein loop of Neisseria meningitidis. Infect Immun 2000;68:1871–1878.
Sacchi CT, Lemos AP, Popovic T, De Morais JC, Whitney AM, Melles CE, et al. Serosubtypes and PorA types of Neisseria meningitidis serogroup B isolated in Brazil during 1997–1998: overview and implications for vaccine development. J Clin Microbiol 2001;39:2897–2903.
Pollard AJ, Galassini R, Roupe van der Voort EM, Booy R, Langford P, Nadel S, et al. Humoral immune responses to Neisseria meningitidis in children. Infect Immun 1999;67:2441–2451.
Meningococcal Disease Surveillance Group. Analysis of endemic meningococcal disease by serogroup and evaluation of chemoprophylaxis. J Infect Dis 1976;134:201–204.
Samuelsson S, Hansen ET, Osler M, Jeune B, et al. Prevention of secondary cases of meningococcal disease in Denmark. Epidemiol Infect 2000;124:433–440.
Scholten RJ, Bijlmer HA, Dankert J, Valkenburg HA. Secondary cases of meningococcal disease in the Netherlands, 1989–1990, a reappraisal of chemoprophylaxis. N ed Tijdschr Geneeskd 1993;137:1505–1508.
Purcell B, Samuelsson S, Hahne SJ, Ehrhard I, Heuberger S, Camaroni I, et al. Effectiveness of antibiotics in preventing meningococcal disease after a case: systematic review. BMJ 2004;328:1339–1344 [Review].
Dawson SJ, Fey RE, McNulty CA. Meningococcal disease in siblings caused by rifampicin-sensitive and resistant strains. Commun Dis Public Health 1999;2:215–216.
Cartwright KA, Stuart JM, Jones DM, Noah ND. The Stonehouse Study: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol Infect 1987;99:591–601.
Ronne T, Berthelsen L, Buhl LH, Lind I. Comparative studies on pharyngeal carriage of Neisseria meningitidis during a localized outbreak of serogroup C meningococcal disease. Scand J Infect Dis 1993;25:331–339.
Cooke RP, Riordan T, Jones DM, Pa inter MJ. Secondary cases of meningococcal infection among close family and household contacts in England and Wales, 1984 –7. BMJ 1989;298:555–558.
Pollard AJ, Begg N. Meningococcal disease and healthcare workers. BMJ 1999;319:1147–1148.
Robinson P, Taylor K, Tallis G, Carnie J, Rouch G, Griffith J , et al. An outbreak of serogroup C meningococcal disease associated with a secondary school. Commun Dis Intell 2001;25:121–125.
Pollard AJ, Probe G, Trombley C, Castell A, Whitehead S, Bigham JM , et al. Evaluation of a diagnostic polymerase chain reaction assay for Neisseria meningitidis in North America and field experience during an outbreak. Arch Pathol Lab Med 2002;126:1209–1215.
Tzanakaki G, Tsolia M, Vlachou V, Theodoridou M, Pangalis A, Foustoukou M, et al. Evaluation of non-culture diagnosis of invasive meningococcal disease by polymerase chain reaction (PCR). FEMS Immunol Med Microbiol 2003;39:31–36.
Newcom be J, Cartwright K, Palmer WH, McFadden J. PCR of peripheral blood for diagnosis of meningococcal disease. J Clin Microbiol 1996;34:1637–1640.
Pardo F, Juncal R, Rajo C, Perez del Molino ML. Usefulness of polymerase chain reaction (PCR) in the diagnosis of meningococcal meningitis. Enferm Infecc Microbiol Clin 1999;17:74–77.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2005 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
